Boston's Cancer Care Rivalry Heats Up with Major Gifts

Dana-Farber and Mass General Brigham Announce Expansions Funded by Prominent Donors

Apr. 13, 2026 at 6:09am

Got story updates? Submit your updates here. ›

A highly detailed, translucent X-ray image of a human lung, revealing the intricate structures and internal workings of the organ in a conceptual representation of advanced medical technology and cancer research.Boston's cancer care rivalry heats up as major donations fuel new high-tech facilities and research initiatives.Boston Today

Boston's top healthcare providers, Dana-Farber and Mass General Brigham (MGB), are engaged in a high-stakes rivalry over cancer care, fueled by substantial donations from wealthy benefactors. Dana-Farber recently received its largest-ever gift, while MGB also secured a major donation to support its own cancer institute expansion. This competition raises questions about the influence of philanthropy on healthcare decisions and the need to balance investments in teaching hospitals with efforts to improve equitable access across the state.

Why it matters

The influx of donations to Dana-Farber and MGB highlights the growing competition between Boston's top healthcare systems as they vie for dominance in cancer care. This rivalry could impact the distribution of resources and the accessibility of advanced cancer treatments for patients across Massachusetts. Additionally, the debate over the role of major gifts in shaping healthcare priorities underscores the complex dynamics between providers, donors, and the communities they serve.

The details

Dana-Farber announced a record-breaking donation from the Bekensteins and Lavines, which will fund a new $1.68 billion, 300-bed cancer hospital. This surpasses Dana-Farber's previous largest gift of $78 million from the Pan-Mass Challenge. Meanwhile, MGB received a $35 million donation from Irving Oil to support the development of its own cancer institute, including renovations at Brigham and Women's Hospital and the construction of a $1.9 billion facility. The competition between Dana-Farber and MGB has been further complicated by Dana-Farber's acrimonious breakup with Brigham and Women's Hospital in 2023, leading to a new partnership with Beth Israel Deaconess Medical Center.

  • Dana-Farber announced the record-breaking donation on April 13, 2026.
  • MGB received the $35 million gift from Irving Oil in 2025.
  • Dana-Farber's partnership with Beth Israel Deaconess Medical Center is set to begin in 2028.

The players

Dana-Farber

A leading cancer care and research institute in Boston.

Mass General Brigham (MGB)

The parent corporation of Brigham and Women's Hospital and Massachusetts General Hospital, two of Boston's top healthcare providers.

Bekensteins and Lavines

Prominent Boston families who donated the largest single gift in Dana-Farber's history.

Irving Oil

A Canadian energy company that donated $35 million to support MGB's cancer institute expansion.

Alan Sager

A professor of health policy who raises concerns about the distribution of healthcare resources and the influence of major gifts.

Got photos? Submit your photos here. ›

What they’re saying

“How much cancer care should be centralized at major teaching hospitals, and how much can be effectively delivered closer to home?”

— Alan Sager, Professor of Health Policy

What’s next

The partnership between Dana-Farber and Beth Israel Deaconess Medical Center is set to begin in 2028, further shaping the landscape of cancer care in Boston. Additionally, MGB's intensive marketing campaign to promote its cancer institute will continue as it competes with Dana-Farber and other providers for patients and resources.

The takeaway

The influx of major donations to Boston's top healthcare providers highlights the intense competition for dominance in cancer care, but it also raises important questions about the role of philanthropy in shaping healthcare priorities. As the rivalry between Dana-Farber and MGB intensifies, policymakers and community leaders will need to carefully consider how to balance investments in teaching hospitals with efforts to improve equitable access to quality cancer care across the state.